Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
228,3 USD | -1,99% | -6,67% | -1,31% |
Omzet 2024 * | 84,68 mln. 79,4 mln. | Omzet 2025 * | 361 mln. 338 mln. | Marktkapitalisatie | 4,79 mld. 4,49 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -451 mln. -423 mln. | Nettowinst (verlies) 2025 * | -284 mln. -266 mln. | EV/omzet 2024 * | 55,5 x |
Nettoliquiditeiten 2024 * | 93,53 mln. 87,69 mln. | Nettoschuld 2025 * | 116 mln. 109 mln. | EV/omzet 2025 * | 13,6 x |
K/w-verhouding 2024 * |
-10,1
x | K/w-verhouding 2025 * |
-16
x | Werknemers | 376 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,04% |
Recentste transcriptie over Madrigal Pharmaceuticals, Inc.
1 dag | -1,99% | ||
1 week | -6,67% | ||
Lopende maand | -14,49% | ||
1 maand | -15,55% | ||
3 maanden | -4,84% | ||
6 maanden | +62,50% | ||
Lopend jaar | -1,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Chiang
FOU | Founder | - | 01-09-11 |
William Sibold
CEO | Chief Executive Officer | - | 08-09-23 |
Rebecca Taub
FOU | Founder | 71 | 01-07-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 78 | 01-09-11 | |
Julian Baker
CHM | Chairman | 57 | 15-06-23 |
Ken Bate
BRD | Director/Board Member | 73 | 22-07-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.35% | 0 M€ | 0,00% | - | |
0.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 228,3 | -1,99% | 247 289 |
16-04-24 | 233 | +0,70% | 343 900 |
15-04-24 | 231,4 | -2,21% | 322 999 |
12-04-24 | 236,6 | -3,54% | 294 909 |
11-04-24 | 245,3 | +0,25% | 216 428 |
uitgestelde koers Nasdaq, 17 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,31% | 4,89 mld. | |
-3,39% | 102 mld. | |
+2,61% | 96,09 mld. | |
-1,02% | 22,05 mld. | |
-18,14% | 20,81 mld. | |
-6,87% | 19,06 mld. | |
-40,70% | 16,05 mld. | |
-26,89% | 14,01 mld. | |
+1,12% | 13,38 mld. | |
+22,25% | 11,01 mld. |